Aberrant activated β-catenin signaling in colon cancer enhanced glycolysis; meanwhile, an NR4A1-β-catenin feed-forward loop happening in colon cancer cells proves from the side that NR4A1 may be involved in promoting glycolysis. This evidence concerns the gene NR4A1 and colonic neoplasm.